ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.830
-0.030 (-1.61%)
At close: Apr 28, 2026, 4:00 PM EDT
1.860
+0.030 (1.64%)
After-hours: Apr 28, 2026, 5:15 PM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $552.59 million as of April 28, 2026. Its market cap has increased by 207.51% in one year.
Market Cap
552.59M
Enterprise Value
286.61M
1-Year Change
207.51%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $552.59M, an increase of 113.52%. That is a compound annual growth rate of 17.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 561.60M | -16.66% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 602.90M |
| Aclaris Therapeutics | 597.68M |
| Zevra Therapeutics | 595.88M |
| Adlai Nortye | 592.00M |
| Shattuck Labs | 585.00M |
| CorMedix | 581.94M |
| Prothena Corporation | 578.70M |
| Ocugen | 561.94M |